Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology
Ming‐Ling Chang, Sien‐Sing Yang
Cells (2019) Vol. 8, Iss. 11, pp. 1423-1423
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact
Willian A. da Silveira, Hossein Fazelinia, Sara Brin Rosenthal, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1185-1201.e20
Open Access | Times Cited: 269
Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection
Torben Kimhofer, Samantha Lodge, Luke Whiley, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 11, pp. 4442-4454
Open Access | Times Cited: 175
The m6A reader IGF2BP2 regulates glycolytic metabolism and mediates histone lactylation to enhance hepatic stellate cell activation and liver fibrosis
Yongqiang Zhou, Jiexi Yan, He Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 17
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions
Mengyao Yan, Cui Yi-min, Qian Xiang
Theranostics (2025) Vol. 15, Iss. 5, pp. 1715-1740
Open Access | Times Cited: 1
Systemic Perturbations in Amine and Kynurenine Metabolism Associated with Acute SARS-CoV-2 Infection and Inflammatory Cytokine Responses
Nathan G. Lawler, Nicola Gray, Torben Kimhofer, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 5, pp. 2796-2811
Closed Access | Times Cited: 94
Important Considerations for Sample Collection in Metabolomics Studies with a Special Focus on Applications to Liver Functions
Lorraine Smith, Joran Villaret-Cazadamont, Sandrine P. Claus, et al.
Metabolites (2020) Vol. 10, Iss. 3, pp. 104-104
Open Access | Times Cited: 83
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 68
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
Xiaochun Yin, Peng Jin, Lihong Gu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 33
Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol
Yang Zheng, Lei Wang, Jiaru Wang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 19, pp. 2821-2837
Closed Access | Times Cited: 5
Amino Acid Hepatotoxicity Biomarkers in Human Hepatic Organoids: Promising Standardization of Drug Toxicity Evaluation
Haneul Noh, Seohyun Choi, Kyung Won Park, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 510-521
Closed Access
Bmal1 inhibits phenotypic transformation of hepatic stellate cells in liver fibrosis via IDH1/α-KG-mediated glycolysis
Lei Xu, Tianyu Yang, Yiwen Zhou, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 2, pp. 316-329
Open Access | Times Cited: 32
Functional mechanisms and potential therapeutic strategies for lactylation in liver disease
Rong Xu, Yitong Hao, Yahui Liu, et al.
Life Sciences (2025) Vol. 363, pp. 123395-123395
Open Access
Machine learning-based plasma metabolomics for improved cirrhosis risk stratification
Jingru Song, Z. Gao, Ling‐Ping Lai, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Targeting fatty acid metabolism for fibrotic disorders
Seonghwan Hwang, Ki Wung Chung
Archives of Pharmacal Research (2021) Vol. 44, Iss. 9-10, pp. 839-856
Closed Access | Times Cited: 28
Switching diseased cells from cytosolic aerobic glycolysis to mitochondrial oxidative phosphorylation: A metabolic rhythm regulated by melatonin?
Russel J. Reíter, Ramaswamy Sharma, Qiang Ma
Journal of Pineal Research (2020) Vol. 70, Iss. 1
Closed Access | Times Cited: 31
The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice
Ming-Yang Tsai, Wei‐Cheng Yang, Chuen‐Fu Lin, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1937-1937
Open Access | Times Cited: 24
A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients
Meera Shanmuganathan, M. Omair Sarfaraz, Zachary Kroezen, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 24
Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization
Naga Chalasani, Shusuke Toden, John J. Sninsky, et al.
AJP Gastrointestinal and Liver Physiology (2021) Vol. 320, Iss. 4, pp. G439-G449
Open Access | Times Cited: 23
The role of hepatic microenvironment in hepatic fibrosis development
Ying Meng, Tong Zhao, Zhengyi Zhang, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 2829-2843
Open Access | Times Cited: 18
Dysregulated systemic metabolism in a Down syndrome mouse model
Dylan C. Sarver, Cheng Xu, Leandro M Velez, et al.
Molecular Metabolism (2022) Vol. 68, pp. 101666-101666
Open Access | Times Cited: 16
Exosomes from adipose-derived mesenchymal stem cells improve liver fibrosis by regulating the miR-20a-5p/TGFBR2 axis to affect the p38 MAPK/NF-κB pathway
Lihong Gan, Zheng Li, Ling Yao, et al.
Cytokine (2023) Vol. 172, pp. 156386-156386
Closed Access | Times Cited: 10
Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis
Diren Beyoğlu, Pinzhu Huang, Disha Skelton-Badlani, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 485-485
Open Access | Times Cited: 9
Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway
Yan Xue, Wanchun Zhu, Fengjie Qiao, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118169-118169
Open Access | Times Cited: 3
miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression
Juan Fu, Biao Wu, Shaohua Zhong, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 529, Iss. 4, pp. 922-929
Closed Access | Times Cited: 23
Perivascular adipose tissue in autoimmune rheumatic diseases
Hong Shi, Hanping Wu, Michael Winkler, et al.
Pharmacological Research (2022) Vol. 182, pp. 106354-106354
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top